Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer-Reference-Cited by-同舟云学术

Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer

Published:2017-11-14 Issue:1 Volume:78 Page:25-31
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kalsbeek Anton M. F.¹²^ORCID,Chan Eva K. F.¹²,Grogan Judith³⁴⁵,Petersen Desiree C.¹²,Jaratlerdsiri Weerachai¹,Gupta Ruta³⁴⁵,Lyons Ruth J.¹,Haynes Anne-Maree⁵,Horvath Lisa G.⁴⁵⁶,Kench James G.³⁴⁵^ORCID,Stricker Phillip D.⁷,Hayes Vanessa M.¹²⁴⁵^ORCID

Affiliation:

1. Laboratory for Human Comparative and Prostate Cancer Genomics; Genomics and Epigenetics Division; Garvan Institute of Medical Research; Darlinghurst New South Wales Australia

2. School of Medical Sciences; University of New South Wales Sydney; Randwick New South Wales Australia

3. Department of Tissue Pathology and Diagnostic Oncology; Royal Prince Alfred Hospital; Camperdown New South Wales Australia

4. Central Clinical School; Sydney Medical School; University of Sydney; Camperdown New South Wales Australia

5. Cancer Research Division; The Kinghorn Cancer Center; Garvan Institute of Medical Research; Darlinghurst New South Wales Australia

6. Chris O'Brien Lifehouse; Camperdown New South Wales Australia

7. Department of Urology; St. Vincent's Hospital; Darlinghurst New South Wales Australia

Funder

Perpetual IMPACT Fund, Australia

Sydney Medical School Foundation

Prostate Cancer Foundation of Australia

Movember Australia

Petre Foundation

Australian Prostate Cancer Research Center New South Wales (APCRC-NSW)

Prostate Cancer Bone Metastasis

Movember Revolutionary Team Award

Publisher

Wiley

Subject

Urology,Oncology

Reference38 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2015

2. The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort;Albertsen;J Urol,2007

5. The molecular taxonomy of primary prostate cancer;Cell,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis;Discover Oncology;2024-07-24

2. Mitochondria transcription and cancer;Cell Death Discovery;2024-04-08

3. Recent advances of nucleic acid-based cancer biomarkers and biosensors;Coordination Chemistry Reviews;2023-12

4. Identifying Mitochondrial Transcription Factor A As a Potential Biomarker for the Carcinogenesis and Prognosis of Prostate Cancer;Genetic Testing and Molecular Biomarkers;2023-01-01

5. Insights regarding mitochondrial DNA copy number alterations in human cancer (Review);International Journal of Molecular Medicine;2022-06-16